Kyleena® – Demonstrated ease of insertion
Investigator evaluation of insertion procedure3*
In an open-label, phase III pivotal trial, study investigators reported that they found the procedure easy to perform in the following women:3
of all women
of nulliparous women
of parous women
The study included 1,452 women aged 18-35 including 39.5% (574) nulliparous women.3
* Results from a multi-centre international, open-label, randomized clinical study for 3 years with an extension to 5 years in 1,452 women aged 18-35 evaluating the contraceptive efficacy of Kyleena® (levonorgestrel-releasing intrauterine system [19.5 mg]).